Correction to: Multiple Sclerosis and Demyelinating Disorders (2017) 2:3.
https://doi.org/10.1186/s40893-017-0020-8
After publication of the article [1], it has been brought to our attention that the full funding acknowledgement is missing from the original article. It should also include the following –
“This work was supported by the Instituto de Salud Carlos III with FEDER funds (Otra forma de hacer Europa) from the European Commission (FIS: PI12/01823)”.
Reference
Moreno B, Vila G, Fernandez-Diez B, Vázquez R, di Penta A, Errea O, et al. Methylthioadenosine promotes remyelination by inducing oligodendrocyte differentiation. Multiple Sclerosis and Demyelinating Disorders. 2017;2(1).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
About this article
Cite this article
Moreno, B., Vila, G., Fernandez-Diez, B. et al. Correction to: Methylthioadenosine promotes remyelination by inducing oligodendrocyte differentiation. Mult Scler Demyelinating Disord 4, 3 (2019). https://doi.org/10.1186/s40893-019-0040-7
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s40893-019-0040-7